Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Licochalcone D may be a potential drug for human melanoma treatment by inhibiting proliferation, inducing apoptosis via the mitochondrial pathway and blocking cell migration and invasion. Licochalcone D has cardioprotective potential against myocardial ischemia/reperfusion injury in langendorff-perfused rat hearts. Licochalcone D has anti-inflammatory activity, it shows suppression ability of nitric oxide (NO) production. Licochalcone D has anti-allergic activity, it suppresses degranulation by decreasing the intracellular Ca2+ level and tyrosine phosphorylation of ERK in RBL-2H3 cells.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 97.00 | |
5 mg | In stock | $ 297.00 | |
10 mg | In stock | $ 443.00 | |
25 mg | In stock | $ 718.00 | |
50 mg | In stock | $ 992.00 | |
100 mg | In stock | $ 1,330.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 327.00 |
Description | Licochalcone D may be a potential drug for human melanoma treatment by inhibiting proliferation, inducing apoptosis via the mitochondrial pathway and blocking cell migration and invasion. Licochalcone D has cardioprotective potential against myocardial ischemia/reperfusion injury in langendorff-perfused rat hearts. Licochalcone D has anti-inflammatory activity, it shows suppression ability of nitric oxide (NO) production. Licochalcone D has anti-allergic activity, it suppresses degranulation by decreasing the intracellular Ca2+ level and tyrosine phosphorylation of ERK in RBL-2H3 cells. |
Source |
Molecular Weight | 354.4 |
Formula | C21H22O5 |
CAS No. | 144506-15-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 3.54 mg/mL (10 mM)
Ethanol: Soluble
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Licochalcone D 144506-15-0 MAPK NF-Κb NF-κB ERK Apoptosis A375 anti-cancer antioxidant Reactive Oxygen Species Nuclear factor-κB NF-κB p65 Nuclear factor-kappaB Inhibitor anti-inflammatory inhibit inhibitor